• Celldex Therapeutics, Inc. (NASDAQ:CLDX) Given Consensus Recommendation of "Moderate Buy" by Analysts

    Source: Buzz FX / 28 Dec 2024 01:37:12   America/Chicago


    Celldex Therapeutics, Inc. (NASDAQ:CLDX) Given Consensus Recommendation of "Moderate Buy" by Analysts Written by MarketBeat December 28, 2024 Share Link copied to clipboard. Shares of Celldex Therapeutics, Inc.
    Read more...
Share on,